What is it about?
Although considerable research has been conducted on anti-modified citrullinated vimentin (anti-MCV) regarding RA, further investigation is imperative to ascertain the precise role of anti-MCV antibodies in the diagnosis and prognosis of RA. Our study aimed at assessing the clinical significance of anti-MCV antibodies in RA patients by investigating the association between anti-MCV antibodies and clinical, functional, and radiographic characteristics of RA patients.
Featured Image
Photo by Chang Duong on Unsplash
Why is it important?
Early detection of RA is crucial to mitigating symptoms such as joint deterioration, physical impairment, and fatigue. Auto-antibodies present in RA may serve as biomarkers that enhance early diagnosis, prognosis, and treatment decisions
Perspectives
I think it's valuable research, as anti-MCV antibodies could help diagnose RA early and resolve the problem of diagnosing seronegative RA patients.
assistant professor Rehab Abdelaal Elnemr
Alexandria University
Read the Original
This page is a summary of: Clinical significance of anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients, Human Antibodies, April 2024, IOS Press,
DOI: 10.3233/hab-240007.
You can read the full text:
Contributors
The following have contributed to this page
